Factors impacting on quality of life in Parkinson's disease: Results from an international survey

Leslie Findley, Tobias Eichhorn, Aleksandar Janca, Joerg Kazenwadel, Mary Baker, Daniela Currie-Gnjesda, William Koller, Abraham Liebermann, Yoshikuno Mizuno, Ali Rajput, Sheila Roy, Fabrizio Stocchi, Eduardo Tolosa

Research output: Contribution to journalArticle

Abstract

Current management guidelines for the treatment of patients with Parkinson's disease (PD) are limited due to the lack of knowledge of factors that influence health-related quality of life (HRQL). To assess the HRQL of people with PD, and to systematically identify and evaluate those factors (other than disease severity and medication, which could have an impact), we undertook a cross- sectional, randomized selection, multicenter international survey of patients with PD, caregivers, and clinicians. Face-to-face interviews were conducted with subjects in six countries. Disease severity, medication, and other factors hypothesized to influence HRQL were assessed using a combination of specially developed questionnaires and validated instruments including the Parkinson's Disease Questionnaire-39 (HRQL), Hoehn and Yahr Stage (disease severity), and Beck's Depression Inventory (BDI; depression). Multiple linear regression models were used to demonstrate whether the factors investigated contribute significantly to HRQL. The results obtained indicated that Hoehn and Yahr stage and medication explained only 17.3% of the variability in HRQL of patients with PD, although both were significant (R2 = 0.173, P <0.05). Other factors increased the explanatory power to adjusted R2 = 0.597, with BDI being the most significant predictor of variability in HRQL (adjusted R2 = 0.582; P <0.001), followed by "Satisfaction with the explanation of the condition at diagnosis" and "Current feelings of optimism" (both P <0.05). These factors, in addition to disease severity and medication, explain 59.7% of the variability in HRQL across the population. In conclusion, depression (as measured by the BDI) in PD, "satisfaction with the explanation of the condition at diagnosis" and "current feelings of optimism" have a significant impact on HRQL. The completion of this initial analysis is the first step towards developing management guidelines that truly influence the HRQL of patients with PD.

Original languageEnglish
Pages (from-to)60-67
Number of pages8
JournalMovement Disorders
Volume17
Issue number1
DOIs
Publication statusPublished - Jan 2002

Fingerprint

Parkinson Disease
Quality of Life
Depression
Linear Models
Emotions
Surveys and Questionnaires
Guidelines
Caregivers
Interviews
Equipment and Supplies
Population

Keywords

  • Beck's depression inventory
  • Parkinson's disease
  • Quality of life

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Findley, L., Eichhorn, T., Janca, A., Kazenwadel, J., Baker, M., Currie-Gnjesda, D., ... Tolosa, E. (2002). Factors impacting on quality of life in Parkinson's disease: Results from an international survey. Movement Disorders, 17(1), 60-67. https://doi.org/10.1002/mds.10010

Factors impacting on quality of life in Parkinson's disease : Results from an international survey. / Findley, Leslie; Eichhorn, Tobias; Janca, Aleksandar; Kazenwadel, Joerg; Baker, Mary; Currie-Gnjesda, Daniela; Koller, William; Liebermann, Abraham; Mizuno, Yoshikuno; Rajput, Ali; Roy, Sheila; Stocchi, Fabrizio; Tolosa, Eduardo.

In: Movement Disorders, Vol. 17, No. 1, 01.2002, p. 60-67.

Research output: Contribution to journalArticle

Findley, L, Eichhorn, T, Janca, A, Kazenwadel, J, Baker, M, Currie-Gnjesda, D, Koller, W, Liebermann, A, Mizuno, Y, Rajput, A, Roy, S, Stocchi, F & Tolosa, E 2002, 'Factors impacting on quality of life in Parkinson's disease: Results from an international survey', Movement Disorders, vol. 17, no. 1, pp. 60-67. https://doi.org/10.1002/mds.10010
Findley L, Eichhorn T, Janca A, Kazenwadel J, Baker M, Currie-Gnjesda D et al. Factors impacting on quality of life in Parkinson's disease: Results from an international survey. Movement Disorders. 2002 Jan;17(1):60-67. https://doi.org/10.1002/mds.10010
Findley, Leslie ; Eichhorn, Tobias ; Janca, Aleksandar ; Kazenwadel, Joerg ; Baker, Mary ; Currie-Gnjesda, Daniela ; Koller, William ; Liebermann, Abraham ; Mizuno, Yoshikuno ; Rajput, Ali ; Roy, Sheila ; Stocchi, Fabrizio ; Tolosa, Eduardo. / Factors impacting on quality of life in Parkinson's disease : Results from an international survey. In: Movement Disorders. 2002 ; Vol. 17, No. 1. pp. 60-67.
@article{10e926e1a4074449961e8f2c2ee8c798,
title = "Factors impacting on quality of life in Parkinson's disease: Results from an international survey",
abstract = "Current management guidelines for the treatment of patients with Parkinson's disease (PD) are limited due to the lack of knowledge of factors that influence health-related quality of life (HRQL). To assess the HRQL of people with PD, and to systematically identify and evaluate those factors (other than disease severity and medication, which could have an impact), we undertook a cross- sectional, randomized selection, multicenter international survey of patients with PD, caregivers, and clinicians. Face-to-face interviews were conducted with subjects in six countries. Disease severity, medication, and other factors hypothesized to influence HRQL were assessed using a combination of specially developed questionnaires and validated instruments including the Parkinson's Disease Questionnaire-39 (HRQL), Hoehn and Yahr Stage (disease severity), and Beck's Depression Inventory (BDI; depression). Multiple linear regression models were used to demonstrate whether the factors investigated contribute significantly to HRQL. The results obtained indicated that Hoehn and Yahr stage and medication explained only 17.3{\%} of the variability in HRQL of patients with PD, although both were significant (R2 = 0.173, P <0.05). Other factors increased the explanatory power to adjusted R2 = 0.597, with BDI being the most significant predictor of variability in HRQL (adjusted R2 = 0.582; P <0.001), followed by {"}Satisfaction with the explanation of the condition at diagnosis{"} and {"}Current feelings of optimism{"} (both P <0.05). These factors, in addition to disease severity and medication, explain 59.7{\%} of the variability in HRQL across the population. In conclusion, depression (as measured by the BDI) in PD, {"}satisfaction with the explanation of the condition at diagnosis{"} and {"}current feelings of optimism{"} have a significant impact on HRQL. The completion of this initial analysis is the first step towards developing management guidelines that truly influence the HRQL of patients with PD.",
keywords = "Beck's depression inventory, Parkinson's disease, Quality of life",
author = "Leslie Findley and Tobias Eichhorn and Aleksandar Janca and Joerg Kazenwadel and Mary Baker and Daniela Currie-Gnjesda and William Koller and Abraham Liebermann and Yoshikuno Mizuno and Ali Rajput and Sheila Roy and Fabrizio Stocchi and Eduardo Tolosa",
year = "2002",
month = "1",
doi = "10.1002/mds.10010",
language = "English",
volume = "17",
pages = "60--67",
journal = "Movement Disorders",
issn = "0885-3185",
publisher = "John Wiley and Sons Inc.",
number = "1",

}

TY - JOUR

T1 - Factors impacting on quality of life in Parkinson's disease

T2 - Results from an international survey

AU - Findley, Leslie

AU - Eichhorn, Tobias

AU - Janca, Aleksandar

AU - Kazenwadel, Joerg

AU - Baker, Mary

AU - Currie-Gnjesda, Daniela

AU - Koller, William

AU - Liebermann, Abraham

AU - Mizuno, Yoshikuno

AU - Rajput, Ali

AU - Roy, Sheila

AU - Stocchi, Fabrizio

AU - Tolosa, Eduardo

PY - 2002/1

Y1 - 2002/1

N2 - Current management guidelines for the treatment of patients with Parkinson's disease (PD) are limited due to the lack of knowledge of factors that influence health-related quality of life (HRQL). To assess the HRQL of people with PD, and to systematically identify and evaluate those factors (other than disease severity and medication, which could have an impact), we undertook a cross- sectional, randomized selection, multicenter international survey of patients with PD, caregivers, and clinicians. Face-to-face interviews were conducted with subjects in six countries. Disease severity, medication, and other factors hypothesized to influence HRQL were assessed using a combination of specially developed questionnaires and validated instruments including the Parkinson's Disease Questionnaire-39 (HRQL), Hoehn and Yahr Stage (disease severity), and Beck's Depression Inventory (BDI; depression). Multiple linear regression models were used to demonstrate whether the factors investigated contribute significantly to HRQL. The results obtained indicated that Hoehn and Yahr stage and medication explained only 17.3% of the variability in HRQL of patients with PD, although both were significant (R2 = 0.173, P <0.05). Other factors increased the explanatory power to adjusted R2 = 0.597, with BDI being the most significant predictor of variability in HRQL (adjusted R2 = 0.582; P <0.001), followed by "Satisfaction with the explanation of the condition at diagnosis" and "Current feelings of optimism" (both P <0.05). These factors, in addition to disease severity and medication, explain 59.7% of the variability in HRQL across the population. In conclusion, depression (as measured by the BDI) in PD, "satisfaction with the explanation of the condition at diagnosis" and "current feelings of optimism" have a significant impact on HRQL. The completion of this initial analysis is the first step towards developing management guidelines that truly influence the HRQL of patients with PD.

AB - Current management guidelines for the treatment of patients with Parkinson's disease (PD) are limited due to the lack of knowledge of factors that influence health-related quality of life (HRQL). To assess the HRQL of people with PD, and to systematically identify and evaluate those factors (other than disease severity and medication, which could have an impact), we undertook a cross- sectional, randomized selection, multicenter international survey of patients with PD, caregivers, and clinicians. Face-to-face interviews were conducted with subjects in six countries. Disease severity, medication, and other factors hypothesized to influence HRQL were assessed using a combination of specially developed questionnaires and validated instruments including the Parkinson's Disease Questionnaire-39 (HRQL), Hoehn and Yahr Stage (disease severity), and Beck's Depression Inventory (BDI; depression). Multiple linear regression models were used to demonstrate whether the factors investigated contribute significantly to HRQL. The results obtained indicated that Hoehn and Yahr stage and medication explained only 17.3% of the variability in HRQL of patients with PD, although both were significant (R2 = 0.173, P <0.05). Other factors increased the explanatory power to adjusted R2 = 0.597, with BDI being the most significant predictor of variability in HRQL (adjusted R2 = 0.582; P <0.001), followed by "Satisfaction with the explanation of the condition at diagnosis" and "Current feelings of optimism" (both P <0.05). These factors, in addition to disease severity and medication, explain 59.7% of the variability in HRQL across the population. In conclusion, depression (as measured by the BDI) in PD, "satisfaction with the explanation of the condition at diagnosis" and "current feelings of optimism" have a significant impact on HRQL. The completion of this initial analysis is the first step towards developing management guidelines that truly influence the HRQL of patients with PD.

KW - Beck's depression inventory

KW - Parkinson's disease

KW - Quality of life

UR - http://www.scopus.com/inward/record.url?scp=0036460864&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036460864&partnerID=8YFLogxK

U2 - 10.1002/mds.10010

DO - 10.1002/mds.10010

M3 - Article

C2 - 11835440

AN - SCOPUS:0036460864

VL - 17

SP - 60

EP - 67

JO - Movement Disorders

JF - Movement Disorders

SN - 0885-3185

IS - 1

ER -